Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Mar 1;434(1):202-6.
doi: 10.1016/j.ab.2012.11.010. Epub 2012 Dec 3.

Interaction of cepharanthine with immobilized heat shock protein 90α (Hsp90α) and screening of Hsp90α inhibitors

Affiliations

Interaction of cepharanthine with immobilized heat shock protein 90α (Hsp90α) and screening of Hsp90α inhibitors

Jun Haginaka et al. Anal Biochem. .

Erratum in

  • Anal Biochem. 2013 May 15;436(2):65

Abstract

Heat shock protein 90α (Hsp90α) immobilized on aminopropyl silica gels was prepared via the N- or C-terminal, which was termed Hsp90α-NT or Hsp90α-CT, respectively. Binding interactions of biscoclaurine alkaloids (cepharanthine (CEP), berbamine (BBM), isotetrandrine (ITD), and cycleanine (CCN)) with Hsp90α were examined using the Hsp90α-NT or -CT columns by frontal and zonal chromatography studies. The dissociation constants of CEP, BBM, ITD, and CCN to Hsp90α-NT were estimated to be 5.3, 18.6, 46.3, and 159 μM, respectively, by frontal chromatography techniques. Similar results were obtained with the Hsp90α-CT column. These data suggest that these biscoclaurine alkaloids interact with the middle domain of Hsp90α. This was confirmed by demonstrating that CEP competed with endothelial nitric oxide synthase at the middle domain of Hsp90α, where it was shown to have a dissociation constant of 15 nM. Furthermore, the Hsp90α-NT column was applied for preliminary screening of natural Hsp90α inhibitors by zonal chromatography studies.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Structures of CEP, BBM, ITD, and CCN.
Fig. 2
Fig. 2
Determination of the dissociation constants of CEP to (a) Hsp90α-NT and (b) Hsp90α-CT columns by frontal chromatography techniques. LC conditions: column, Hsp90α-NT or Hsp90α-CT (20 × 5.0 mm i.d.); mobile phase, 10 mM Tris–HCl buffer (pH 7.4) containing various concentrations of CEP; flow rate, 0.2 ml/min; column temperature, 25 °c; detection, 282 nm; injection volume, 5 ml.
Fig. 3
Fig. 3
Relationship for competitive displacement of CEP by eNOS. LC conditions: column, Hsp90α-NT (20 × 5.0 mm i.d.); mobile phase, 10 mM Tris–HCl buffer (pH 7.4) containing various concentrations of eNOS; flow rate, 0.2 ml/min; column temperature, 25 °c; detection, 210 nm; amount loaded, 500 ng.
Fig. 4
Fig. 4
Plots of the retention times of natural products on Hsp90α-NT and control-NT columns. LC conditions: column, Hsp90α-NT or control-NT (20 × 5.0 mm i.d.); mobile phase, 10 mM Tris–HCl buffer (pH 7.4); flow rate, 0.2 ml/min; column temperature, 25 °c; detection, 210 nm; amount loaded, 500 ng. Symbols: 1, CEP; 2, BBM; 3, ITD; 4, CCN; 5, quercetin; 6, curcumin; 7, wogonin; 8, glycyrrhizin; 9, baicalin; 10, baicalein; 11, ginsenoside.

References

    1. Whitesell L, Lidquist SL. HSP90 and the chaperoning of cancer. Nat. Rev. Cancer. 2005;5:761–772. - PubMed
    1. Shames DS, Minna JD. IP6K2 is a client for HSP90 and a target for cancer therapeutics development. Proc. Natl. Acad. Sci. USA. 2008;105:1389–1390. - PMC - PubMed
    1. Workman P. Altered states: selectively drugging the Hsp90 cancer chaperone. Trends Mol. Med. 2004;10:47–51. - PubMed
    1. Calderwood SK, Khaleque MA, Sawyer DB, Ciocca DR. Heat shock proteins in cancer: chaperones of tumorigenesis. Trends Biochem. Sci. 2006;31:164–172. - PubMed
    1. Kasibhatla SR, Hong K, Biamonte MA, Busch DJ, Karjian PL, Sensintaffar JL, Kamal A, Lough RE, Brekken J, Lundgren K, Grecko R, Timony GA, Mansfield RR, Fritz LC, Ulm E, Burrows FJ, Boehm MF. Rationally designed high-affinity 2-amino-6-halopurine heat shock protein 90 inhibitors that exhibit potent antitumor activity. J. Med. Chem. 2007;50:2767–2778. - PubMed

Publication types

MeSH terms

LinkOut - more resources